Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

MILL molecules are unique immune proteins in mice that don't need TAP to appear on cell surfaces.

Diphencyprone is effective for treating patchy hair loss in alopecia areata, but tacrolimus is not.

Different substances affect hair and skin cell growth in various ways, with some promoting and others inhibiting cell proliferation.

RANKL improves the immune response against herpes simplex virus by enhancing T cell activation and could help develop better treatments or vaccines.

Lichen planopilaris may be an autoimmune disease causing hair loss due to immune system issues in hair follicles.

Inactive stem cells in hair follicles and muscles can avoid detection by the immune system.

Stress-related substance P may lead to hair loss and negatively affect hair growth.

Transplant success has improved with better immunosuppressive drugs and donor matching.

The nail matrix has a reduced immune response, protecting it from autoimmunity.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.

Immune privilege collapse in hair follicles may cause permanent hair loss in certain conditions.

Hair follicles could help develop eye treatments by studying immune responses.

Hepatitis B virus exposure may be linked to increased risk of alopecia areata.

Rats can develop an immune response to prion protein peptides, but it may cause severe skin issues in older rats.

Hair follicle stem cells reduced hair loss and inflammation in mice with a condition similar to human alopecia.

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

Blocking certain immune signals can reduce skin damage from radiation therapy.

Cells from the lower part of hair follicles are a promising, less invasive option for immune system therapies.

UV light helped human hair transplants survive in mice without broad immunosuppression.

Alopecia areata in children is caused by the immune system attacking hair follicles due to genetic factors.

EGFRi/MEKi treatments cause hair follicles to lose some immune protection, leading to inflammation.

Hair loss treatment caused more hair loss in a man.

Sorafenib may cause hair loss in a way similar to alopecia areata.

The skin protects the body, regulates temperature, senses touch, and makes vitamin D.

Restoring immune privilege in hair follicles could help treat certain types of hair loss.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

ILC1 cells contribute to hair loss in alopecia areata.

Farudodstat may effectively treat alopecia areata without harmful side effects.

Farudodstat may effectively treat alopecia areata without harming hair follicles.